Yvette van Bekkum is a nonclinical drug development expert with more than 28 years of experience spanning toxicology, safety pharmacology, and nonclinical regulatory strategy across multiple therapeutic areas and modalities, including small molecules and biologics. She currently advises biotech and pharmaceutical companies as a Senior Consultant at J&S Preclinical Solutions. Previously, she held senior leadership roles at Organon, Schering-Plough, MSD, and Johnson & Johnson, where she served as Vice President and Global Head of Toxicology & Safety Pharmacology. Yvette holds a PhD in Medical Sciences from Radboud University Nijmegen, The Netherlands.

At Allegria, Yvette contributes her expertise in translational safety, toxicology, and regulatory development, helping to de-risk programs and advance innovative mast cell-targeted therapies toward the clinic.

Connect on LinkedIn.